2nd Adaptive Clinical Trials Symposium Brochure Released!
Wednesday January 9th, 2019
ExL Events is excited to announce the release of the highly anticipated brochure for the 2nd Adaptive Clinical Trials Symposium, which takes place March 18–19 at the Sonesta Hotel in Philadelphia.
During this two-day Summit, industry professionals will convene to further educate the important aspects when utilizing these major benefits and implementing this innovative design, such as reducing the trial length and obtaining more precise conclusions for the benefit of trial participants.
Through interactive sessions, panel discussions, and case studies, the 2nd Adaptive Clinical Trials Symposium will explore the unconventional progression behind developing, using and implementing an adaptive design in order to proactively boost clinical research and effectively lower costs. You will leave the Symposium with better comprehension analyzing statistics, data, and operations through an adaptive design for more efficient clinical trials.
Case Study: Discuss the Evolvement of Data Collection With Neurological Diseases
Alex Sverdlov, Director, Statistical Scientist, NOVARTIS
Discuss the Availability of Good Quality Data in Biomarker-Driven Clinical Trials
Abdel Halim, VP Translational Medicine, Biomarkers and Diagnostics, CELLDEX THERAPEUTICS
Implement Strategies and Innovative Tactics Designed to Maintain Patients Enrolled in Clinical Trials
Rebecca Vanlandingham, Associate Director, TEVA PHARMACEUTICALS
Identify Trial Operation Errors and Corrections to Maintain Compliance
Rajesh Shukla, VP Clinical Research and Operations, CASTLE CREEK PHARMACEUTICALS
Register today and do not miss out on this premier learning platform and networking experience. Don’t forget to use Priority Code 700119EM2.
From The Blog
- Commercial Strategy
- Content Marketing
- Data Management
- Digital Marketing
- Drug Safety
- Emerging Markets
- ExL Events News
- Medical Devices
- Medical Education
- Meeting Planning
- Patient Engagement
- Public/Government Relations
- Regulatory Affairs